News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Senators Probe Medtronic, Inc. (MDT), Johnson & Johnson (JNJ), Others on High-profile Recalls


12/19/2011 7:10:43 AM

A bipartisan trio of Senators probes Medtronic, Johnson & Johnson and three other med-tech titans on recent high-profile recalls as the legislators push for heightened safety measures. Three U.S. senators are probing med-tech titans on recent high-profile recalls, including Medtronic's (NYSE:MDT) 2007 Sprint Fidelis recall and Johnson & Johnson's (NYSE:JNJ) more recent metal-on-metal hip implant woes. Sens. Chuck Grassley (R-Iowa), Herb Kohl (D-Wis.) and Richard Blumenthal (D-Conn.) sent investigative letters to 5 device makers, asking them about their post-market surveillance and recall management practices. The trio asked Medtronic to dish on its precedent-setting Fidelis recall, which was implicated in more than 100 deaths (Medtronic has said that only 13 fatalities had the leads as a "possible or likely contributing factor"). Fidelis was the company's top product at the time.

Read at MassDevice
Read at Star Tribune
Read at Journal Sentinel
Read at Bloomberg

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES